Schering-Plough to evaluate Peg-Intron in combined disease (Hepatitis C Infection)

Schering-Plough to evaluate Peg-Intron in combined disease
Pharmaceutical Business Review - Jan 16 6:28 PM
Schering-Plough is set to initiate a large multinational clinical trial to evaluate the use of low-dose Peg-Intron maintenance monotherapy in patients who are infected with both hepatitis C and HIV.Save to My Web

Inovio and Tripep to Develop Hepatitis C Vaccine
RedNova - Jan 17 7:29 PM
Inovio Biomedical has signed an agreement with Swedish-based Tripep to develop a therapeutic vaccine for hepatitis C virus.Save to My Web

Idenix and Novartis Seek European Approval of Telbivudine for the Treatment of Patients with Chronic Hepatitis B
[Press Release] PR Newswire via Yahoo! Finance - Feb 07 5:00 AM
Idenix Pharmaceuticals, Inc. and Novartis announced today the submission of a Marketing Authorization Application to the European Medicines Agency seeking marketing authorization for the 600 mg dose of telbivudine for the treatment of chronic hepatitis B.Save to My Web

Health Business
UPI - Jan 23 1:27 PM
VANCOUVER, British Columbia, Jan. 23 (UPI) -- Migenix said Monday it would launch early in the second quarter of 2006 a trial of hepatitis C drug MX-3253.Save to My Web